+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Test Location (PoC, Homecare), By End-use, By Application, By Technology, By Province, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 136 Pages
  • June 2023
  • Region: Canada
  • Grand View Research
  • ID: 5846832
Description Jump to:
The Canada in vitro diagnostics market size is expected to reach USD 4.36 billion by 2030, registering a CAGR of 2.6% during the forecast period, according to this report. Increasing R&D for the development of the technologically advanced in vitro diagnostics (IVD) systems for laboratories & hospitals to provide efficient, accurate, and error-free diagnosis is expected to fuel market growth. Moreover, the outbreak of COVID-19 disease has increased the growth at a significant rate.

High susceptibility to infections among the geriatric population is anticipated to increase the demand for in vitro diagnostic testing in Canada over the forecast period. The geriatric population is more likely to suffer from COVID-19 due to decreased immune function. According to the government of Canada, there were around 353,000 deaths between March 2020 and mid-May 2021, and people aged 65 and above accounted for around 80% of those deaths.

The country’s leading causes of death include heart disorders, cancer, chronic lower respiratory diseases, cerebrovascular diseases, and diabetes. Heart diseases and cancer accounted for the majority of deaths in Canada. Moreover, death rates from other disorders such as chronic lower respiratory diseases and cirrhosis/chronic liver disease have increased in recent years. The increasing number of cases of diabetes in Canada is anticipated to fuel market growth, with more than 10% of the population currently diagnosed with diabetes.

Moreover, the technological advancements in IVD testing are also expected to boost market growth during the forecast period. For instance, in February 2021, Thermo Fisher Scientific received approval from Health Canada for Applied Biosystems TaqPath COVID-19 HT Kit. Moreover, in June 2020, F. Hoffmann-La Roche Ltd received authorization for the Elecsys Anti-SARS-CoV-2 serology test under Health Canada’s Interim Order to make it available for laboratories and healthcare professionals. The introduction of novel products is expected to drive growth.

Key players in the Canada IVD industry are investing to expand their range of testing by undertaking R&D initiatives for the development of kits that target emerging diseases or by entering into agreements with other key manufacturing companies. In addition, innovative product launch in the market is a result of increasing R&D efforts and partnership programs established by players. For instance, in May 2021, LaunchWorks, a CDMO in molecular diagnostics, and Canadienzyme, a biotech spin-off company by two McGill University scientists, collaborated to produce RT-qPCR Master Mix, RT-qPCR testing reagent. Such initiatives undertaken by key players are expected to propel the market growth in the country.

Canada In Vitro Diagnostics Market Report Highlights

  • By technology, the molecular diagnostics segment held the largest revenue share in 2022, due to the increasing adoption of these tests for the detection of COVID-19 infection
  • Based on technology, the coagulation segment is expected to register the highest CAGR during the forecast period, owing to higher adoption of IVD assays and a rise in demand for point-of-care diagnostics
  • By application, the infectious diseases segment held the largest revenue share in 2022 owing to the rising prevalence of infectious diseases and the high adoption of IVDs for the detection of infectious diseases
  • The hospital segment held the largest share of the Canada IVD market in 2022, whereas the homecare segment is expected to register the highest CAGR rate during the forecast period


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using A Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Canada Ivd Market Variables, Trends, & Scope
4.1 Ivd Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Growing Geriatric Population
4.4.2 Technological Advancements
4.4.3 Increasing Demand For Poc Facilities
4.4.4 Growing Prevalence Of Target Diseases, Such As Genetic, Cardiovascular, & Neurological Diseases, And Hospital-Acquired Infections
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Higher Cost Of Devices
4.5.2 Stringent Regulatory Policies
4.6 Value Chain Analysis
4.6.1 Value Chain Analysis/Route To Market
4.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
4.8 Porter’s Five Forces Analysis
4.9 Consumer Behavior Analysis
4.10 Major Deals And Strategic Alliances Analysis
4.10.1 New Product Launch
4.10.2 Mergers And Acquisitions
4.10.3 Expansion
4.10.4 Partnerships
4.10.5 Marketing & Promotions
4.10.6 Market Entry Strategies
4.10.7 Mergers And Deals
Chapter 5 Canada Ivd Market - Segment Analysis, By Product, 2018 - 2030 (USD Million) (Volume, Number Of Tests & Instruments)
5.1 Canada In Vitro Diagnostic Market: Product Movement Analysis
5.2 Instruments
5.2.1 Instruments Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Instruments
5.3 Reagents
5.3.1 Reagents Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests
5.4 Services
5.4.1 Services Market Estimates And Forecast, (2018 - 2030 USD Million)
Chapter 6 Canada Ivd Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million) (Volume, Number Of Tests & Instruments)
6.1 Canada In Vitro Diagnostics Market: Technology Movement Analysis
6.2 Immunoassay
6.2.1 Immunoassay Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.2.2 Instruments
6.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, (2018 - 2030 USD Million)
6.2.3 Reagents
6.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, (2018 - 2030 USD Million)
6.2.4 Services
6.2.4.1 Services Market For Immunoassay Estimates And Forecast, (2018 - 2030 USD Million)
6.3 Hematology
6.3.1 Hematology Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.3.2 Instruments
6.3.2.1 Instruments Market For Hematology Estimates And Forecast, (2018 - 2030 USD Million)
6.3.3 Reagents
6.3.3.1 Reagents Market For Hematology Estimates And Forecast, (2018 - 2030 USD Million)
6.3.4 Services
6.3.4.1 Services Market For Hematology Estimates And Forecast, (2018 - 2030 USD Million)
6.4 Clinical Chemistry
6.4.1 Clinical Chemistry Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.4.2 Instruments
6.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, (2018 - 2030 USD Million)
6.4.3 Reagents
6.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, (2018 - 2030 USD Million)
6.4.4 Services
6.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, (2018 - 2030 USD Million)
6.5 Molecular Diagnostics
6.5.1 Molecular Diagnostics Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.5.2 Instruments
6.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, (2018 - 2030 USD Million)
6.5.3 Reagents
6.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, (2018 - 2030 USD Million)
6.5.4 Services
6.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, (2018 - 2030 USD Million)
6.6 Coagulation
6.6.1 Coagulation Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.6.2 Instruments
6.6.2.1 Instruments Market For Coagulation Estimates And Forecast, (2018 - 2030 USD Million)
6.6.3 Reagents
6.6.3.1 Reagents Market For Coagulation Estimates And Forecast, (2018 - 2030 USD Million)
6.6.4 Services
6.6.4.1 Services Market For Coagulation Estimates And Forecast, (2018 - 2030 USD Million)
6.7 Microbiology
6.7.1 Microbiology Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.7.2 Instruments
6.7.2.1 Instruments Market For Microbiology Estimates And Forecast, (2018 - 2030 USD Million)
6.7.3 Reagents
6.7.3.1 Reagents Market For Microbiology Estimates And Forecast, (2018 - 2030 USD Million)
6.7.4 Services
6.7.4.1 Services Market For Microbiology Estimates And Forecast, (2018 - 2030 USD Million)
6.8 Others
6.8.1 Others Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
6.8.2 Instruments
6.8.2.1 Instruments Market Estimates And Forecast, (2018 - 2030 USD Million)
6.8.3 Reagents
6.8.3.1 Reagents Market Estimates And Forecast, (2018 - 2030 USD Million)
6.8.4 Services
6.8.4.1 Services Market Estimates And Forecast, (2018 - 2030 USD Million)
Chapter 7 Canada Ivd Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
7.1 Canada In Vitro Diagnostic Market: Application Movement Analysis
7.2 Infectious Diseases
7.2.1 Infectious Diseases Market Estimates And Forecast, (2018 - 2030 USD Million)
7.3 Diabetes
7.3.1 Diabetes Market Estimates And Forecast, (2018 - 2030 USD Million)
7.4 Oncology
7.4.1 Oncology Market Estimates And Forecast, (2018 - 2030 USD Million)
7.5 Cardiology
7.5.1 Cardiology Market Estimates And Forecast, (2018 - 2030 USD Million)
7.6 Nephrology
7.6.1 Nephrology Market Estimates And Forecast, (2018 - 2030 USD Million)
7.7 Autoimmune Diseases
7.7.1 Autoimmune Diseases Market Estimates And Forecast, (2018 - 2030 USD Million)
7.8 Drug Testing
7.8.1 Drug Testing Market Estimates And Forecast, (2018 - 2030 USD Million)
7.9 Others
7.9.1 Others Market Estimates And Forecast, (2018 - 2030 USD Million)
Chapter 8 Canada Ivd Market - Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
8.1 Canada In Vitro Diagnostic Market: End-Use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market Estimates And Forecast, (2018 - 2030 USD Million)
8.3 Laboratory
8.3.1 Laboratory Market Estimates And Forecast, (2018 - 2030 USD Million)
8.4 Home Care
8.4.1 Home Care Market Estimates And Forecast, (2018 - 2030 USD Million)
8.5 Others
8.5.1 Other Market Estimates And Forecast, (2018 - 2030 USD Million)
Chapter 9 Canada Ivd Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)
9.1 Canada In Vitro Diagnostic Market: Test Location Movement Analysis
9.2 Point Of Care
9.2.1 Point-Of-Care Market Estimates And Forecast, (2018 - 2030 USD Million)
9.3 Homecare
9.3.1 Homecare Market Estimates And Forecast, (2018 - 2030 USD Million)
9.4 Laboratories
9.4.1 Laboratories Market Estimates And Forecast, (2018 - 2030 USD Million)
Chapter 10 Canada Ivd Market - Segment Analysis, By Province, 2018 - 2030 (USD Million) (Volume, Number Of Tests & Instruments)
10.1 Canada In Vitro Diagnostic Market: Province Movement Analysis
10.2 Canada
10.2.1 Canada, Swot Analysis
10.2.2 Canada Market Estimates And Forecast, (2018 - 2030 USD Million)
10.2.3 Ontario
10.2.3.1 Ontario Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.4 Quebec
10.2.4.1 Quebec Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.5 West Canada
10.2.5.1 West Canada Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.5.2 Alberta
10.2.5.2.1 Alberta Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.5.3 Saskatchewan
10.2.5.3.1 Saskatchewan Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.5.4 Manitoba
10.2.5.4.1 Manitoba Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.5.5 British Columbia
10.2.5.5.1 British Columbia Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.6 East Canada
10.2.6.1 East Canada Market Estimates And Forecast, (2018 - 2030 USD Million)
10.2.6.2 Nova Scotia
10.2.6.2.1 Nova Scotia Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.6.3 Prince Edward Island
10.2.6.3.1 Prince Edward Island Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.6.4 New Brunswick
10.2.6.4.1 New Brunswick Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.6.5 Newfoundland And Labrador
10.2.6.5.1 Newfoundland And Labrador Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
10.2.7 Rest Of Canada
10.2.7.1 Rest Of Canada Market Estimates And Forecast, (2018 - 2030 USD Million), Volume, Number Of Tests & Instruments
Chapter 11 Competitive Analysis
11.1 Recent Developments & Impact Analysis, By Key Market Participants
11.1.1 Ansoff Matrix
11.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
11.1.3 Innovators
11.2 Vendor Landscape
11.2.1 List Of Key Distributors And Channel Partners
11.2.2 Canada Ivd Market: Key Company Market Share Analysis, 2022
11.3 Public Companies
11.3.1 Company Market Position Analysis
11.3.2 Competitive Dashboard Analysis
11.3.3 Strategic Framework
11.4 Company Profiles
11.4.1 ABBOTT
11.4.1.1 Company overview
11.4.1.2 Financial performance
11.4.1.3 Product benchmarking
11.4.1.4 Strategic initiatives
11.4.2 BIOMERIEUX SA
11.4.2.1 Company overview
11.4.2.2 Financial performance
11.4.2.3 Product benchmarking
11.4.2.4 Strategic initiatives
11.4.3 BIO-RAD LABORATORIES, INC.
11.4.3.1 Company overview
11.4.3.2 Financial performance
11.4.3.3 Product benchmarking
11.4.3.4 Strategic initiatives
11.4.4 BD
11.4.4.1 Company overview
11.4.4.2 Financial performance
11.4.4.3 Product benchmarking
11.4.4.4 Strategic initiatives
11.4.5 QIAGEN
11.4.5.1 Company overview
11.4.5.2 Financial performance
11.4.5.3 Product benchmarking
11.4.5.4 Strategic initiatives
11.4.6 AGILENT TECHNOLOGIES
11.4.6.1 Company overview
11.4.6.2 Financial performance
11.4.6.3 Product benchmarking
11.4.6.4 Strategic initiatives
11.4.7 DANAHER CORPORATION
11.4.7.1 Company overview
11.4.7.2 Financial performance
11.4.7.3 Product benchmarking
11.4.8 QUEST DIAGNOSTICS
11.4.8.1 Company overview
11.4.8.2 Financial performance
11.4.8.3 Product benchmarking
11.4.8.4 Strategic initiatives
11.4.9 SYSMEX CORPORATION
11.4.9.1 Company overview
11.4.9.2 Financial performance
11.4.9.3 Product benchmarking
11.4.9.4 Strategic initiatives
11.4.10 F. HOFFMANN-LA ROCHE LTD
11.4.10.1 company overview
11.4.10.2 Financial performance
11.4.10.3 Product benchmarking
11.4.10.4 Strategic initiatives
11.4.11 QUIDEL CORPORATION
11.4.11.1 Company overview
11.4.11.2 Financial performance
11.4.11.3 Product benchmarking
11.4.11.4 Strategic initiatives
11.4.12 SIEMENS HEALTHINEERS AG
11.4.12.1 Company overview
11.4.12.2 Financial performance
11.4.12.3 Product benchmarking
11.4.12.4 Strategic initiatives
11.4.13 SEEGENE INC.
11.4.13.1 Company overview
11.4.13.2 Financial performance
11.4.13.3 Product benchmarking
11.4.13.4 Strategic initiatives
11.4.14 HOLOGIC, INC.
11.4.14.1 Company overview
11.4.14.2 Financial performance
11.4.14.3 Product benchmarking
11.4.15 ORTHO CLINICAL DIAGNOSTICS
11.4.15.1 Company overview
11.4.15.2 Financial performance
11.4.15.3 Product benchmarking
11.4.16 WERFEN
11.4.16.1 Company overview
11.4.16.2 Product benchmarking
11.4.17 LUMINEX CORPORATION
11.4.17.1 Company overview
11.4.17.2 Product benchmarking
11.4.17.3 Strategic initiatives
11.4.18 PTS DIAGNOSTICS
11.4.18.1 Company overview
11.4.18.2 Product benchmarking
11.4.19 THERMO FISHER SCIENTIFIC, INC.
11.4.19.1 Company overview
11.4.19.2 Financial performance
11.4.19.3 Product benchmarking
11.4.19.4 Strategic initiatives
11.4.20 NOVA BIOMEDICAL
11.4.20.1 Company overview
11.4.20.2 Product benchmarking
11.4.20.3 Strategic initiatives
11.4.21 NTBIO DIAGNOSTICS INC.
11.4.21.1 Company overview
11.4.21.2 Product benchmarking
11.4.22 SAKURA FINETEK USA, INC.
11.4.22.1 Company overview
11.4.22.2 Product benchmarking
11.4.22.3 Strategic initiatives
List of Tables
Table 1: List of secondary sources
Table 2: List of abbreviations
Table 3: List of key IVD tests for COVID-19
Table 4: Prevalence & incidence of diseases in Canada (in thousand)
Table 5: List of pipeline products
Table 6: List of key distributors and channel partners
Table 7: List of key customers
Table 8: Company market share analysis, 2022
Table 9: Canada IVD Market, By Province, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 10: Canada IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 11: Canada IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 12: Canada IVD Market, By Application, 2018-2030 (USD Million)
Table 13: Canada IVD Market, By End-use, 2018-2030 (USD Million)
Table 14: Canada IVD Market, By Test Location, 2018-2030 (USD Million)
Table 15: Ontario IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 16: Ontario IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 17: Ontario IVD Market, By Application, 2018-2030 (USD Million)
Table 18: Ontario IVD Market, By End-use, 2018-2030 (USD Million)
Table 19: Ontario IVD Market, By Test Location, 2018-2030 (USD Million)
Table 20: Quebec IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 21: Quebec IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 22: Quebec IVD Market, By Application, 2018-2030 (USD Million)
Table 23: Quebec IVD Market, By End-use, 2018-2030 (USD Million)
Table 24: Quebec IVD Market, By Test Location, 2018-2030 (USD Million)
Table 25: West Canada IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 26: West Canada IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 27: West Canada IVD Market, By Application, 2018-2030 (USD Million)
Table 28: West Canada IVD Market, By End-use, 2018-2030 (USD Million)
Table 29: West Canada IVD Market, By Test Location, 2018-2030 (USD Million)
Table 30: Alberta IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 31: Alberta IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 32: Alberta IVD Market, By Application, 2018-2030 (USD Million)
Table 33: Alberta IVD Market, By End-use, 2018-2030 (USD Million)
Table 34: Alberta IVD Market, By Test Location, 2018-2030 (USD Million)
Table 35: Saskatchewan IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 36: Saskatchewan IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 37: Saskatchewan IVD Market, By Application, 2018-2030 (USD Million)
Table 38: Saskatchewan IVD Market, By End-use, 2018-2030 (USD Million)
Table 39: Saskatchewan IVD Market, By Test Location, 2018-2030 (USD Million)
Table 40: Manitoba IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 41: Manitoba IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 42: Manitoba IVD Market, By Application, 2018-2030 (USD Million)
Table 43: Manitoba IVD Market, By End-use, 2018-2030 (USD Million)
Table 44: Manitoba IVD Market, By Test Location, 2018-2030 (USD Million)
Table 45: British Columbia IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 46: British Columbia IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 47: British Columbia IVD Market, By Application, 2018-2030 (USD Million)
Table 48: British Columbia IVD Market, By End-use, 2018-2030 (USD Million)
Table 49: British Columbia IVD Market, By Test Location, 2018-2030 (USD Million)
Table 50: East Canada IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 51: East Canada IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 52: East Canada IVD Market, By Application, 2018-2030 (USD Million)
Table 53: East Canada IVD Market, By End-use, 2018-2030 (USD Million)
Table 54: East Canada IVD Market, By Test Location, 2018-2030 (USD Million)
Table 55: Nova Scotia IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 56: Nova Scotia IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 57: Nova Scotia IVD Market, By Application, 2018-2030 (USD Million)
Table 58: Nova Scotia IVD Market, By End-use, 2018-2030 (USD Million)
Table 59: Nova Scotia IVD Market, By Test Location, 2018-2030 (USD Million)
Table 60: Prince Edward Island IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 61: Prince Edward Island IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 62: Prince Edward Island IVD Market, By Application, 2018-2030 (USD Million)
Table 63: Prince Edward Island IVD Market, By End-use, 2018-2030 (USD Million)
Table 64: Prince Edward Island IVD Market, By Test Location, 2018-2030 (USD Million)
Table 65: New Brunswick IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 66: New Brunswick IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 67: New Brunswick IVD Market, By Application, 2018-2030 (USD Million)
Table 68: New Brunswick IVD Market, By End-use, 2018-2030 (USD Million)
Table 69: New Brunswick IVD Market, By Test Location, 2018-2030 (USD Million)
Table 70: Newfoundland and Labrador IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 71: Newfoundland and Labrador IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 72: Newfoundland and Labrador IVD Market, By Application, 2018-2030 (USD Million)
Table 73: Newfoundland and Labrador IVD Market, By End-use, 2018-2030 (USD Million)
Table 74: Newfoundland and Labrador IVD Market, By Test Location, 2018-2030 (USD Million)
Table 75: Rest of Canada IVD Market, By Product, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 76: Rest of Canada IVD Market, By Technology, 2018-2030 (USD Million), (Number of Tests & Instruments)
Table 77: Rest of Canada IVD Market, By Application, 2018-2030 (USD Million)
Table 78: Rest of Canada IVD Market, By End-use, 2018-2030 (USD Million)
Table 79: Rest of Canada IVD Market, By Test Location, 2018-2030 (USD Million)
List of Figures
Fig. 1: Canada In Vitro Diagnostics market segmentation
Fig. 2: Market research process
Fig. 3: Data triangulation techniques
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: In vitro diagnostic market snapshot
Fig. 10: Parent market outlook
Fig. 11: Penetration and growth prospect mapping
Fig. 12: Canada In vitro diagnostic market driver impact
Fig. 13: Global population by age group, 2016 & 2027
Fig. 14: Canada elderly population
Fig. 15: New cancer cases by year
Fig. 16: In vitro diagnostic market restraint impact
Fig. 17: Market entry strategy
Fig. 18: SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 19: Porter’s five forces analysis
Fig. 20: Consumer behavior analysis
Fig. 21: Strategy mapping
Fig. 22: Canada IVD market: Product outlook and key takeaways
Fig. 23: Canada IVD market: Product movement analysis
Fig. 24: Instruments market estimates and forecast, 2018-2030 (USD Million), Number of Instruments
Fig. 25: Reagents market estimates and forecast, 2018-2030 (USD Million), Number of Tests
Fig. 26: Services market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Canada IVD market: Technology outlook and key takeaways
Fig. 28: Canada IVD Market: Technology movement analysis
Fig. 29: Immunoassay market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 30: Instruments market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Reagents market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 32: Services market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Fig. 33: Hematology market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 34: Instruments market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Reagents market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 36: Services market for hematology estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Clinical chemistry market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 38: Instruments market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Reagents market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Services market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Fig. 41: Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 42: Instruments market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Reagents market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Services market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Coagulation market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 46: Instruments market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Reagents market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Services market for coagulation estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Microbiology market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 50: Instruments market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Reagents market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 52: Services market for microbiology estimates and forecast, 2018-2030 (USD Million)
Fig. 53: Others market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 54: Instruments others market estimates and forecast, 2018-2030 (USD Million)
Fig. 55: Reagents others market estimates and forecast, 2018-2030 (USD Million)
Fig. 56: Services market for other technology estimates and forecast, 2018-2030 (USD Million)
Fig. 57: Canada IVD market: Application outlook and key takeaways
Fig. 58: Canada IVD market: Application movement analysis
Fig. 59: Infectious diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Diabetes market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: Oncology market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: Cardiology market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Nephrology market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: Autoimmune diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 65: Drug testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 66: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 67: Canada IVD market: End-use outlook and key takeaways
Fig. 68: Canada IVD treatment market: End-use movement analysis
Fig. 69: Hospitals market estimates and forecast, 2018-2030 (USD Million)
Fig. 70: Laboratory market estimates and forecast, 2018-2030 (USD Million)
Fig. 71: Home care market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Primary care market estimates and forecast, 2018-2030 (USD Million)
Fig. 73: Other market estimates and forecast, 2018-2030 (USD Million)
Fig. 74: Canada IVD market: Test location outlook and key takeaways
Fig. 75: Canada IVD treatment market: Test location movement analysis
Fig. 76: Point-of-care market estimates and forecast, 2018-2030 (USD Million)
Fig. 77: Homecare market estimates and forecast, 2018-2030 (USD Million)
Fig. 78: Laboratories market estimates and forecast, 2018-2030 (USD Million)
Fig. 79: Canada IVD Market: Province outlook and key takeaways
Fig. 80: Canada IVD market: Province movement analysis
Fig. 81: Ontario key country dynamics
Fig. 82: Ontario market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 83: Quebec key country dynamics
Fig. 84: Quebec market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 85: West Canada key country dynamics
Fig. 86: West Canada market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 87: Alberta key country dynamics
Fig. 89: Alberta market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 90: Saskatchewan key country dynamics
Fig. 91: Saskatchewan market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 92: Manitoba key country dynamics
Fig. 93: Manitoba market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 94: British Columbia key country dynamics
Fig. 95: British Columbia market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 96: East Canada key country dynamics
Fig. 97: East Canada market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 98: Nova Scotia key country dynamics
Fig. 99: Nova Scotia Island market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 98: Prince Edward Island key country dynamics
Fig. 99: Prince Edward Island market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 100: New Brunswick key country dynamics
Fig. 101: New Brunswick market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 102: Newfoundland and Labrador key country dynamics
Fig. 104: Newfoundland and Labrador market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 105: Rest of Canada key country dynamics
Fig. 106: Rest of Canada market estimates and forecast, 2018-2030 (USD Million), Number of Tests & Instruments
Fig. 107: Ansoff matrix
Fig. 108: Competition categorization
Fig. 109: Company market share analysis
Fig. 110: Company profiles

Companies Mentioned

  • ABBOTT
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • BD
  • QIAGEN
  • AGILENT TECHNOLOGIES
  • DANAHER CORPORATION
  • QUEST DIAGNOSTICS
  • SYSMEX CORPORATION
  • F. HOFFMANN-LA ROCHE LTD
  • QUIDEL CORPORATION
  • SIEMENS HEALTHINEERS AG
  • SEEGENE INC.
  • HOLOGIC, INC.
  • ORTHO CLINICAL DIAGNOSTICS
  • WERFEN
  • LUMINEX CORPORATION
  • PTS DIAGNOSTICS
  • THERMO FISHER SCIENTIFIC, INC.
  • NOVA BIOMEDICAL
  • NTBIO DIAGNOSTICS INC.
  • SAKURA FINETEK USA, INC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages136
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.36 Billion
Compound Annual Growth Rate2.6%
Regions CoveredCanada
No. of Companies Mentioned22

Related Topics

Related Reports

In Vitro Diagnostics - Global Strategic Business Report - Product Image

In Vitro Diagnostics - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2024-2032 - Product Image

In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Global in Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End-use (Hospitals, Laboratory), Application (Diabetes, Oncology), Technology, Region, and Segment Forecasts, 2024-2030 - Product Image

Global in Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End-use (Hospitals, Laboratory), Application (Diabetes, Oncology), Technology, Region, and Segment Forecasts, 2024-2030

  • Report
  • 200 Pages
  • Global
From
IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From

About the In Vitro Diagnostics Market

In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings. IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample. IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer. Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.